Back to top
more

Elanco Animal Health (ELAN)

(Delayed Data from NYSE)

$13.31 USD

13.31
3,809,643

-0.15 (-1.11%)

Updated Apr 24, 2024 04:00 PM ET

After-Market: $13.30 -0.01 (-0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's What Key Metrics Tell Us About Elanco Animal Health Incorporated (ELAN) Q4 Earnings

by Zacks Equity Research

The headline numbers for Elanco Animal Health Incorporated (ELAN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Analysts Estimate U.S. Physical Therapy (USPH) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

U.S. Physical Therapy (USPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Elanco Animal Health Incorporated (ELAN) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

by Zacks Equity Research

Get a deeper insight into the potential performance of Elanco Animal Health Incorporated (ELAN) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for XPH

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

by Zacks Equity Research

Sector ETF report for XPH

Merck (MRK) Unit to Buy Elanco's Aqua Business for $1.3B

by Zacks Equity Research

Merck's (MRK) Animal Health unit is set to strengthen its position with the acquisition of Elanco Animal Health's aqua business for $1.3 billion. The transaction is expected to close by mid-2024.

Strength Seen in Elanco Animal Health Incorporated (ELAN): Can Its 6.2% Jump Turn into More Strength?

by Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Elanco Animal Health Incorporated (ELAN) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Here's What Key Metrics Tell Us About Elanco Animal Health Incorporated (ELAN) Q3 Earnings

by Zacks Equity Research

While the top- and bottom-line numbers for Elanco Animal Health Incorporated (ELAN) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Here's Why Elanco Animal Health Incorporated (ELAN) Is a Great 'Buy the Bottom' Stock Now

by Zacks Equity Research

After losing some value lately, a hammer chart pattern has been formed for Elanco Animal Health Incorporated (ELAN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Implied Volatility Surging for Elanco (ELAN) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Elanco (ELAN) stock based on the movements in the options market lately.

Waters (WAT) Boosts Mass Spectrometry Clientele With Latest Move

by Zacks Equity Research

Waters (WAT) partners with the University of San Agustin to provide the latter with technology equipment in its newly developed mass spectrometry imaging center in the Philippines.

New Strong Buy Stocks for September 19th

by Zacks Equity Research

DHI, DVA, KMTUY, ELAN and BWMX have been added to the Zacks Rank #1 (Strong Buy) List on September 19, 2023.

Best Value Stocks to Buy for September 19th

by Zacks Equity Research

DHI, KMTUY and ELAN made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 19, 2023.

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for XPH

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

by Zacks Equity Research

Sector ETF report for XPH

Stock Market News for Aug 8, 2023

by Zacks Equity Research

Wall Street rebounded on Monday, regaining some of the ground lost last week, as investors digested earnings reports from a batch of companies and waited for key inflation readings scheduled for release later this week.

Elanco Animal Health Incorporated (ELAN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

by Zacks Equity Research

The headline numbers for Elanco Animal Health Incorporated (ELAN) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 260% and 2.03%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Addus HomeCare (ADUS) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 7% and 1.73%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Elanco Animal Health Incorporated (ELAN) Stock Jumps 11.7%: Will It Continue to Soar?

by Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Elanco Animal Health Incorporated (ELAN) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 55.17% and 5.70%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 46.30% and 1.57%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Aveanna Healthcare (AVAH) Q1 Earnings Expected to Decline

by Zacks Equity Research

Aveanna (AVAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.